Keywords: Boehringer Ingelheim, Viramune, Label, Europe, Pradaxa, USA, HIV, Stroke, Embolism

European Commission approves label change for Boehringer Ingelheim’s Viramune; US FDA updates on Pradaxa

Article | 17 September 2010

Print This

The European Commission has approved an update to the Summary of Product Characteristics (SmPC) for independent German drug major Boehringer ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in